Perrigo Company plc (PRGO) | Stock Overview & Key Data
Perrigo Company plc Performance Comparison
Stock Range
Today's Range
Low: $21.32
High: $21.85
on September 16, 2025
52 Week Range
Low: $21.03
High: $30.93
on August 6, 2025
on March 3, 2025
All-Time High: $215.73 on April 6, 2015
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$3.1B
EPS
-0.43
P/E Ratio (TTM)
2,818.00
Forward P/E
7.14
P/B Ratio
0.69
PEG Ratio
-30.50
Div. Yield
N/A
ROE
-1.32%
Beta
0.476
Debt to Equity
86.48
Financial Highlights
Profitability
Gross Margin
34.36%
Operating Margin
6.43%
Profit Margin
-1.85%
Returns and Earnings
Return on Assets (TTM)
3.26%
Return on Equity (TTM)
-1.32%
EBITDA
$744.3M
Net Income (TTM)
$-59.5M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$31.71
Quarterly Revenue Growth (YoY)
-0.90%
Quarterly Earnings Growth (YoY)
-0.86%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Perrigo Company plc PRGO | 3.06B Mid-cap | -2.60% | -4.19% | -18.51% | -23.06% | -16.35% | -19.83% | -42.90% | -51.92% |
| Zoetis ZTS | 65.30B Large-cap | -3.34% | -1.05% | -12.21% | -8.34% | -8.86% | -22.44% | -5.79% | -7.88% |
| Haleon Plc - ADR HLN | 45.42B Large-cap | -0.62% | 0.31% | -9.70% | -6.11% | 2.54% | -7.98% | 63.24% | 30.63% |
| Elanco Animal Health ELAN | 9.21B Mid-cap | -2.15% | 3.79% | 33.24% | 75.19% | 54.69% | 32.48% | 41.00% | -30.58% |
| Regencell Bioscience RGC | 7.27B Mid-cap | 6.85% | 9.38% | -76.08% | 2,828.57% | 10,938.46% | 8,341.18% | 1,788.16% | 5,025.00% |
| Alkermes plc ALKS | 4.38B Mid-cap | -6.78% | -8.71% | -9.86% | -22.84% | -7.76% | -7.11% | 18.82% | 58.42% |
Ownership & Short Interest
Insider Ownership
0.41%
Institutional Ownership
105.88%
Shares Short
7M
Short Ratio
3.94
Short % of Shares Outstanding
6.05%
Average 10-Day Volume
2M
Average 90-Day Volume
2M
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is PRGO's 52-week high and low?
- In the last 52 weeks, Perrigo Company plc reached a high of $30.93 (on March 3, 2025) and a low of $21.03 (on August 6, 2025).
- What is the market cap and P/E ratio for PRGO?
- Curious about Perrigo Company plc's size and valuation? Its market capitalization stands at 3.06B. When it comes to valuation, the P/E ratio (trailing twelve months) is 2,818.00, and the forward P/E (looking ahead) is 7.14.
- Does PRGO pay dividends? If so, what's the yield?
- As for dividends, Perrigo Company plc isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Perrigo Company plc's main competitors or similar companies to consider before investing?
When looking at Perrigo Company plc, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Zoetis
ZTS65.30B Healthcare Drug Manufacturers - Specialty & Generic -22.44% -5.79% Haleon Plc - ADR
HLN45.42B Healthcare Drug Manufacturers - Specialty & Generic -7.98% 63.24% Elanco Animal Health
ELAN9.21B Healthcare Drug Manufacturers - Specialty & Generic 32.48% 41.00% Regencell Bioscience
RGC7.27B Healthcare Drug Manufacturers - Specialty & Generic 8,341.18% 1,788.16% Alkermes plc
ALKS4.38B Healthcare Drug Manufacturers - Specialty & Generic -7.11% 18.82% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Perrigo Company plc? (e.g., ROE, Debt/Equity)
- To get a sense of Perrigo Company plc's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -1.32%, the Debt to Equity ratio from the most recent quarter is 86.48, and its Gross Profit Margin stands at 34.36%.
- What is the recent revenue and earnings growth for PRGO?
- Looking at Perrigo Company plc's growth, its revenue over the trailing twelve months (TTM) was $4B. Compared to the same quarter last year (YoY), quarterly revenue grew by -0.90%, and quarterly earnings saw a YoY growth of -0.86%.
- How much of PRGO stock is held by insiders and institutions?
- Wondering who owns Perrigo Company plc stock? Company insiders (like executives and directors) hold about 0.41% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 105.88%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.